HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 08, August 2019 – Digitalization vs Digitization — Exploring Emerging Trends in Healthcare       » Shanghai neurologists test brain implant to tackle drug addiction       » Gene-editing researchers reduce cancer risk       » Artificial Intelligence in Precision Cancer Diagnostics: Myth or Magic?       » Healing with Technology       » Smart Hospital: An Instrument of Care       » Transforming Healthcare with Data and Artificial Intelligence      
EYE ON CHINA
BGI Partners with NRGene to Provide Broadest Genomic Analysis Available

Ness Ziona, Israel, and Shenzhen, China, August 15, 2016 – BGI, the world’s largest omics organisation, announced today that it will be offering NRGene’s technology as part of its broad genomics analysis services in agriculture research.

BGI supports genomic research worldwide by offering a variety of genetic research and application technologies for the healthcare, agriculture, conservation, and environmental fields. It also publishes the respected international research journal, GigaScience, to further contribute to the genomics community.

NRGene provides genomic assessment and assembly tools that solve the most complex genomic challenges accurately and rapidly. Most recently, NRGene mapped the bread and pasta wheat genomes, which represent the most complex genomes to assemble, in mere weeks rather than years.

“We have recognised the complementary capabilities that NRGene’s and BGI’s technologies provide to the Chinese genomics community, with its wide and diverse challenges,” said Gao Qiang, CEO of BGI Tech. “The combined technologies will transform Asian agriculture.”

NRGene’s DeNovoMAGICTM 2.0 delivers the most accurate reference genomes fast and cost effectively, while PanMAGICTM provides genome-to-genome mapping across varieties. It displays all types of sequence differences and structural variations within the studied genetic material including SNPs, InDels of any size, inversions, translocations, gene PAVs, and gene CNVs.

“Being a selected technology by the world’s leading omics group is a major step forward as we continue to disrupt the genomics industry,” said Dr. Gil Ronen, CEO, NRGene. “Our high quality genomic analysis is already advancing agricultural genomics, and this will help drive us into other markets that are primed to accelerate their research.”

Source: NRGene & K2 Global Comms

Click here for the complete issue.

NEWS CRUNCH  
news Not Science Fiction anymore — the emergence of AI and Robotics in Healthcare
news How blockchain can save the food industry millions from recalls
news China Healthcare and Pharma Digital Innovation Summit
news BIO-PHARM2019 — The Most Influential Forum in China's Biopharm Industry
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy